PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Title only   |   Print    Next page > 
     
Ribo and Madrigal Reach First Major Milestone in Advancing Novel siRNA Therapies for MASH
SUZHOU, China and MÖLNDAL, Sweden , July 2, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. (06938.HK), and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to as "Ribo"), ...
2026-07-02T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NSCLC
SHANGHAI , July 2, 2026 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) today announced that it has entered into a strategic collaboration ...
2026-07-02T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Nona Biosciences and Lonza Enter Strategic Collaboration to Develop Best-in-Class Single-Domain Antibody-Based BBB-Crossing Technology for CNS Diseases
CAMBRIDGE, Mass. , July 2, 2026 /PRNewswire/ -- Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery and development through innovative technology platforms, ...
2026-07-02T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Bredehorst Clinic Medical Management, Germany's Leading Healthcare Procurement Specialist, partners with Sigla
DÜSSELDORF, Germany , July 1, 2026 /PRNewswire/ -- Düsseldorf - Sigla , a European private equity firm, is pleased to announce its investment in Bredehorst Clinic Medical Management GmbH ...
2026-07-01T    Banking/Financial Service   Computer/Electronics   Health Care/Hospital 
NYSE Content Update: Mobility Global Marks First Day as Public Company
NYSE issues a pre-market daily advisory direct from the trading floor. ...
2026-07-01T    Banking/Financial Service   Computer/Electronics   Health Care/Hospital 
STARMED Receives FDA 510(k) Clearance for a Benign Thyroid Nodule Ablation Indication
SEOUL, South Korea , July 1, 2026 /PRNewswire/ -- STARMED, a medical device company specialising in minimally invasive treatment technologies, has announced that it has obtained 510(k) clearance from ...
2026-07-01T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Vitafoods Asia 2026: Science-Backed Botanicals and Next-Generation Probiotics Take Centre Stage
Leading Companies Present Science-Backed Solutions Addressing Antimicrobial Resistance, Digestive Health, and Wellness Through Advanced Probiotics and Clinical Botanicals ...
2026-07-01T    Health Care/Hospital   Medical/Pharmaceuticals 
PharmaResearch Accelerates REJURAN Cosmetics Expansion Across North and South America with Planned Acquisition of CG USA
Acquisition strengthens local manufacturing and logistics capabilities as REJURAN Cosmetics expands across Sephora, Amazon and Canada, with future growth across the Americas in view ...
2026-07-01T    Biotechnology   Computer/Electronics   Cosmetics & Personal Care   Health Care/Hospital 
The Hidden Cost of Efficiency: How Singapore Professionals Manage "Chronic Low-Grade Fatigue"
SINGAPORE , July 1, 2026 /PRNewswire/ -- With locals working an average of 43–45 hours per week, Singapore professionals face widespread "chronic low-grade fatigue." Research in the Journal ...
2026-07-01T    Health Care/Hospital 
Colossal Foundation and University of Tasmania Partner to Combat Devil Facial Tumour Disease with Vaccines and Gene Editing
The collaboration leverages Colossal's marsupial de-extinction and conservation biotechnology platform to save the Tasmanian devil from a contagious cancer that has driven 80% population declines across ...
2026-07-01T    Biotechnology   Computer/Electronics   Environmental Products & Services   Health Care/Hospital 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.